Physician

Ali Kassamali, M.D.

According to 2025 Medicare claims, Ali Kassamali, M.D. (NPI: 1003102898) practices interventional pain management (ipm) in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is QUANTUM ANESTHESIA SERVICES PA (NPI: 1306270806) and primary practice location at 34232-2401.

Kassamali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 401 traditional Medicare patients, billed 2,146 HCPCS/CPT codes, and received $161,357 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,643 prescription claims across 532 beneficiaries totaling $172,324 in drug costs, led by Oxycontin (Oxycodone Hcl). 2018 DME data shows 11 claims. Open Payments data shows 30 records totaling $1,881. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	220	644	$61,112
2017	455	3,848	$351,817
2018	500	3,962	$326,059
2019	748	3,945	$301,116
2020	695	4,944	$335,365
2021	662	4,293	$351,686
2022	619	4,032	$357,906
2023	593	4,080	$347,568
2024	401	2,146	$161,357

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	207	650	$48,575
2017	548	5,693	$448,329
2018	394	5,432	$531,607
2019	731	4,784	$463,532
2020	729	4,530	$323,274
2021	795	4,947	$332,073
2022	783	5,445	$373,652
2023	766	4,778	$311,239
2024	532	2,643	$172,324

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	20	20	$20,603
2018	11	11	$3,290
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	84	113	$195
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	241	366	$85
80307	Testing for presence of drug, by chemistry analyzers	172	231	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	263	413	$59
96136	Administration of psychological or neuropsychological test, first 30 minutes	120	131	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	28	813	$14,738
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	499	14,536	$13,983
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	579	16,310	$12,741
Belbuca	Buprenorphine Hcl	16	465	$12,594
Xtampza Er	Oxycodone Myristate	20	600	$10,578

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,881	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Kassamali, M.D.?

Tedicare shows public-source Medicare data for Ali Kassamali, M.D. (NPI 1003102898), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Kassamali, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Kassamali, M.D.?

Ali Kassamali, M.D. is linked to QUANTUM ANESTHESIA SERVICES PA (billing NPI 1306270806) in the available physician profile data.

Does Ali Kassamali, M.D. have Open Payments data?

Ali Kassamali, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.